Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 278

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 278
---
, 2025 and December
31, 2024, there were $1,006,397 and $98,570 right of use (“ROU”) assets and $1,068,754 and $118,757 lease liabilities based
on the present value of the future minimum rental payments of leases, respectively. The Company’s management believes that using
an incremental borrowing rate of the minimum loan rate and the Hong Kong Dollar Best Lending Rate (“BLR”) minus 0.125% was
the most indicative rate of the Company’s borrowing cost for the calculation of the present value of the lease payments; the rate
used by the Company was 6.6% and 5.5% respectively.

NOTE 12 — EQUITY

Ordinary shares

As at June 30, 2025 and December
31, 2024, the Company is authorized to issue 50,000,000 ordinary shares. Each ordinary share is entitled to one vote. The holders of
ordinary shares are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors
of the Company. On July 4, 2025, the Board of Directors of the Company approved unlimited authorized ordinary share.

The equity of the Company
as of June 30, 2025 and December 31, 2024 represents 1,070,279 and 22,770 ordinary shares with par value of $Nil. The number of shares
as above have taken into consideration the reverse stock split effected on February 11, 2025, May 6, 2025 and August 4, 2025 at an exchange
ratio of one (1) share for twenty (20) shares, one (1) share for ten (10) shares and one (1) share for five (5) share, respectively.
Pursuant to ASC 505 the reverse stock split has been applied retrospectively.

<div align='center'>F-55</div>

Additional paid-in capital

| Balance as at January 1,2023                               |     | $ |  1,464,959 |   |
| Issuance of shares as                                      
 compensation for services (Note 1)                         |     |   |  2,866,856 |   |
| Balance as at December 31, 2023                            |     |   |  4,331,815 |   |
| Issuance of shares through                                 
 Equity Line of Credit